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Three rhesus macaques were infected with an SIVmac239 variant containing substitutions of 73/74PA3ED and 204D3R
in Nef that disrupted the ability of Nef to downregulate CD4 surface expression. One of these animals, Mm8155, rapidly
progressed to AIDS and died 21 weeks postinfection. During the final 5 weeks of infection, the levels of viral RNA and of p27
antigenemia were about 100-fold higher than usually observed in SIVmac239 infection. Postmortem examination revealed
giant cell disease of the lymph nodes and the gastrointestinal tract, opportunistic infections, and a severe chronic enteritis.
The majority of proviruses in spleen, kidney, and lymph nodes, and almost 100% of the viral RNA sequences, contained
mutations of CGA3TAT in codon 17 of nef, predicting a change of 17R3Y. The appearance of this substitution, which has
recently been shown to confer the phenotype of the acutely pathogenic SIVpbj14, coincided with the dramatic increase in
viral load and rapid progression to fatal disease. In comparison, reversions of 204R3D and changes of 72-74NED3DKD,
which restored the ability of Nef to downregulate CD4, were already selected earlier in infection. Similarly to SIVpbj14, virus
reisolated at late time points from Mm8155 replicated efficiently in unstimulated monkey lymphocytes. The Y17 substitution
was not detected in 14 additional SIVmac239-infected macaques at the time of AIDS-related death or in the two slowly
progressing animals initially infected with the same Nef variant. Although infection of macaques with SIV is commonly used
as an animal model for HIV-1 infection in humans, this is only the second example for the emergence of an acutely lethal
SIVmac Nef variant. © 1999 Academic Press
a
m
r
c
Z
t
t
d
D
1
1
w
t
c
1
Y
c
c
o
F
s
v
fINTRODUCTION
Human and simian immunodeficiency viruses (HIV
nd SIV) usually cause immunodeficiency and opportu-
istic infections after long incubation periods. However,
highly unusual strain of SIV, SIVpbj14, which was ob-
ained after serial passage of SIVsmm9 in pig-tailed
acaques, is unique because of its tremendous viru-
ence (Dewhurst et al., 1990; Fultz et al., 1989; Fultz and
ack, 1994; Israel et al., 1993; Lewis et al., 1992; Rosen-
erg et al., 1991; Schwiebert and Fultz, 1994). Experimen-
al infection of pig-tailed macaques with SIVpbj14 typi-
ally results in severe disease and death within 10 days
fter inoculation (Fultz et al., 1989; Fultz and Zack, 1994;
ewis et al., 1992). Infected animals develop acute gas-
roenteritis and diarrhea, associated with severe wasting
nd electrolyte disturbances (Dittmar et al., 1995; Fultz et
l., 1989; Fultz and Zack, 1994; Israel et al., 1993; Lewis et
l., 1992). A striking pathological feature is the extensive
ymphoid hyperplasia occurring predominantly in gut-
ssociated lymphoid tissues (GALT). The SIVpbj14 vari-
1 To whom correspondence and reprint requests should be
ddressed. Fax: 0049-9131-852101. E-mail: fkkirchh@viro.med.uni-nrlangen.de.
61nt is able to replicate well in resting peripheral blood
ononuclear cells (PBMC), whereas HIV and SIV usually
equire activated CD41 T lymphocytes for efficient repli-
ation (Dewhurst et al., 1990; Fultz et al., 1989; Fultz and
ack, 1994; Israel et al., 1993).
Experiments using a series of chimeric clones be-
ween SIVpbj14 and the parental SIVsmm9 were unable
o determine what genetic differences account for this
rastic difference in pathogenicity (Dewhurst et al., 1992;
ittmar et al., 1995; Dollard et al., 1994; Novembre et al.,
993). Subsequently, it was shown that changing residue
7 in Nef of SIVmac239 from R to Y resulted in a virus that
as able to replicate in unstimulated PBMC cultures and
o induce acute disease in pig-tailed and rhesus ma-
aques similarly to SIVpbj14 infection (Du et al., 1995,
996; Sasseville et al., 1996). The R17Y change creates a
xxL motif that, in conjunction with two YxxL/S motifs
lose to the N-terminus of SIVmac239 Nef, resembles
onsensus sequences of SH2 domains binding to motifs
n the cytoplasmic domains of B- and T-cell antigen and
c receptor molecules (Cambier, 1995). These studies
uggest that nef plays a major role in the enhanced
irulence. However, the nef gene of SIVpbj14 is not suf-
icient to confer acute pathogenicity to SIVagm or to a
onpathogenic simian–human immunodeficiency virus
0042-6822/99 $30.00
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62 KIRCHHOFF ET AL.Stephens et al., 1998; Wagener et al., 1998), indicating
hat the viral background is also important.
The SIV/macaque model is commonly used as an
nimal model for the pathogenesis of HIV-1. Nonethe-
ess, after the initial report on SIVpbj14, no additional
tudies have described the appearance of acutely patho-
enic SIV variants in experimentally infected monkeys.
ince primate lentiviruses are generally considered to be
low viruses, it is possible that acutely lethal SIV variants
re an aberration that is hardly ever observed in vivo. It
s unknown whether the R17Y Nef is merely an extremely
ctive allele or whether it has taken on a completely new
unction. It is also largely unclear under which conditions
hese acutely pathogenic variants may have a selective
dvantage over forms expressing “normal” Nef. In this
tudy we show that the acutely pathogenic SIVmac Nef
17Y variant can arise de novo in rhesus macaques
nitially infected with a much less pathogenic SIVmac
ariant. The appearance of the mutation in codon 17
CGA3TAT; R3Y) coincided with a dramatic increase in
iral load, severe pathology in the gastrointestinal tract,
T
In Vitro Activities of Nef Variants Selected
Virusa
Nef aa variationsb
17 72 73 74 204
39wt F N P A D
3/74/204 — — E D R
155–1 wpi — — K15 D R
155–2 wpi — — K30 D —80
155–4 wpi — D40 K50 D —.9
155–8 wpi — D.95 K.95 D —.9
155–12 wpi — D.95 K.95 D —.9
155–16 wpi Y36 D.95 K.95 N20 —.9
155–21 wpi Y51 D.95 K.95 N20 —.9
39nef * — — — — —
xxA — — — — —
3K,74D — — K D —
2-74DKD — D K D —
-DKD Y D K D —
17 Y — — — —
a Molecularly cloned SIVmac239 variants, and virus reisolated by coc
or infectivity and replication assays.
b Most SIVmac239 Nef mutants varied only in the indicated changes
premature in-frame stop signal in nef (Regier and Desrosiers, 1989; K
07 from P to A (Lang et al., 1997). For the reisolates the quantitation of
as determined for nef fragments amplified directly from PBMC DNA
mino acid identity with 239Nef.
c CD4 down-modulation was assayed as described (Skowronski and
n CD4 surface expression. n.d., not determined.
d Infectivity of SIVmac239 compared to the indicated Nef variants in s
ontaining 100 ng of p27 capsid antigen as described (Chackerian e
easurements with four to six different virus stocks.
e PBMC were isolated and infected as described under Materials an
n some experiments; 1, levels of replication detected were between
dpi (stim.); and significantly above background for unstimulated PBMnd rapid progression to death. pRESULTS
Three rhesus macaques were infected intravenously
ith an SIVmac239 variant containing three amino acid
ubstitutions, 73/74PA3ED and 204D3R in Nef. These
hanges disrupt the ability of Nef to downregulate CD4
nd to enhance viral infectivity. In all 3 animals rapid
eversion of 204R3D and alterations at positions 72 to
4, which restored Nef function, were observed (Table 1,
nd data not shown). The in vitro and in vivo properties of
hese Nef variants will be described in more detail else-
here (Iafrate et al., in preparation). Two of these 3
nimals developed a chronic course of infection with
lasma p27 antigen levels always below 1 ng/ml. In the
hird animal, Mm8155, the p27 antigen levels were sim-
lar to infection with nef-defective SIVmac at 2 weeks
ostinfection (wpi) (Fig. 1). Thereafter, the viral load in-
reased to levels similar to those observed in other
IVmac239-infected animals rapidly progressing to dis-
ase (Fig. 1). From 8 to 16 weeks postinfection a slight
ecline from 14.1 to 7.8 ng p27 antigen per milliliter of
8155 and Cloned SIVmac239 Nef Mutants
CD42c sMAGId
PBMCe
Prestim. Stim. Unstim.
111 100 11 11 2
2 21 6 8 11 6 2
n.d. n.d. 11 6 2
n.d. 21 6 5 11 (1) 2
n.d. 42 6 7 11 (1) 2
n.d. 121 6 14 11 1 2
n.d. 105 6 24 11 11 2
n.d. 136 6 21 11 11 1
n.d. 64 6 10 11 11 1
n.d. 10 6 2 11 6 2
111 93 6 17 11 1 2
1 63 6 11 11 1 2
11 86 6 16 11 11 2
n.d. 82 6 13 11 11 1
n.d. 78 6 13 11 11 1
on of PBMCs, obtained from Mm8155 at the indicated wpi, were used
e original nef-open SIVmac239 clone, except 239nef *, which contains
t al., 1991), and AxxA, which contains changes of amino acids 104 and
ions and changes in Nef (percentages are given in lower case letters)
lculated as described previously (Lang et al., 1997). Dashes indicate
i, 1995). 111, strong; 11 slightly reduced; 1, weak, and 2, no effect
indicator cells. sMAGI cells were infected with aliquots of virus stocks
995; Lang et al., 1997). The values represent 12 to 18 independent
ods. 2, no replication detected; 6, low levels of replication detected
50% of those of the original SIVmac239 clone in PBMC stimulated at
, replication comparable to 239wt.ABLE 1
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63EMERGENCE OF THE SIVmac239 17R3Y VARIANTevels increased about 24-fold, to 187.6 ng/ml at the time
f death at 21 weeks postinfection (Fig. 1). In the same
ime-frame the viral RNA load increased about 10-fold
rom 3.6 3 107 copies/ml at 16 wpi to 3.4 3 108 copies/ml
t 20 wpi (data not shown). For comparison, we deter-
ined the p27 levels at the time of AIDS-related death in
1 SIVmac239 wild-type infected macaques and in 2
acaques infected with the AxxA-Nef variant that rapidly
rogressed to AIDS (Lang et al., 1997). In these 13 ani-
als the final p27 values ranged from 0 to 6.3 ng/ml, with
n average value of 1.1 ng/ml. Thus, the levels of p27
iremia observed during the final stage of Mm8155 in-
ection were at least 30-fold higher than those previously
bserved in SIVmac239-infected macaques, including
everal rapid progressors. Even during the acute viremic
hase of infection we never observed p27 values ex-
eeding 12 ng/ml after SIVmac239 wild-type infection
data not shown).
Although the levels of p27 antigenemia increased dra-
atically between 16 and 21 wpi, the cellular viral load
as similar to that observed in other SIVmac239-infected
acaques and decreased slightly during the final weeks
f infection (Fig. 2). Mm8155 showed an early and rapid
ecline in the number of CD41/CD291 T-helper memory
ells by 4 weeks postinfection which preceded that of
he total population of CD41 T-cells (Fig. 3). The loss of
FIG. 1. Rapid increase of p27 antigenemia late in infection of Mm81
3/74ED, 204R variant, in a wild-type infected control animal (Mm7200
Lang et al., 1997) are shown. For clarity the curves are also shown in a
hown for SIVmac239DNU (Gundlach et al., 1997) represents median va
ostinfection; †, time of death. The arrows indicate p27 levels in six 2
etween 14 and 45 weeks postinfection. In seven additional SIVmac23
uantitation limit.D41 blood lymphocytes, which present an important narget for viral infection, may explain the relatively low
requency of infectious cells observed in the final stage.
Shortly before death the number of CD81 cytotoxic
-lymphocytes also showed a remarkable decline (Fig.
). Mm8155 showed ELISA antibody titers of 1:1600 at 8
pi and 1:400 at 12 wpi and no detectable antibodies at
he time of death at 21 wpi (data not shown). These
ntibody titers were much lower than those observed in
he other two macaques infected in parallel (1:3200 and
:6400, respectively, at 8 wpi and 1:102,400 at 24 wpi)
ith the same virus stock. Genetic analysis revealed that
m8155 had a combination of MHC class II alleles (DBQ
601/0601) that was previously described to be associ-
ted with low or undetectable SIV-specific antibody re-
ponse and rapid disease progression (Sauermann et
l., 1997).
Prior to death the animal Mm8155 developed severe
astroenteritis and diarrhea, associated with wasting. At
he time of death, Mm8155 showed opportunistic infec-
ions (Giardia lamblia, Trichomonas, and Cryptosporidi-
im), enlargement of the GALT system, and an erosive-
lcerate gastroenteritis. Macroscopically, the animal
howed marked to severe hyperplasia of mesenteric and
nguinal lymph nodes and the GALT system. Despite the
nlargement of some lymph nodes, the histological anal-
sis showed that some peripheral and internal lymph
sid antigen levels in macaque Mm8155 infected with the SIVmac239
two rapid progressors infected with the SIVmac239 AxxA Nef variant
cale (right). The limit of detection is approximately 20 pg/ml. The curve
btained from four infected animals. dpi, days postinfection; wpi, weeks
d-type infected animals measured at the time of AIDS-related death,
ted macaques tested, the levels of p27 antigenemia were below the55. Cap
wt) and
linear s
lues o
39 wil
9-infecodes had already reached a state of massive depletion,
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64 KIRCHHOFF ET AL.haracterized by a reduction of lymphocytes in the cortex
nd paracortex, a lack of follicles in the cortex area, and
severe fibrosis. A moderate interstitial pneumonia and
moderate depletion of spleen follicles could also be
etected. Furthermore, the lung and all lymphoid tissues
ncluding the GALT exhibited a characteristic SIV-
nduced giant cell disease. The number of CD41 cells in
ymph node (CD41 22.6%; CD41/CD291 7.3%) and spleen
CD41 24.3%; CD41/CD291 5.3%) was reduced. Micro-
lia cells in the brain were strongly activated and capsid
ntigen levels in the cerebrospinal fluid were higher
8450 pg/ml) than those previously observed after SIV-
ac239 infection (0 to 2600 pg/ml). The levels of IL-6 and
FNa increased slightly after 16 wpi. Induction of these
ytokines, however, was not higher than in other rapid
rogressors of SIVmac239 infection (data not shown).
The rapid increase in viremia to exceptionally high
evels prior to death suggested the emergence of a more
athogenic SIVmac variant. Therefore, the status of nef
enes in Mm8155 was examined. At the time of death,
he majority of proviral sequences amplified from kidney
68%), axillary lymph nodes (67%), and spleen (53%) con-
ained three point mutations (CGA3TAT) in codon 17 of
he nef ORF, changing R17 to Y17 (Fig. 4). This change
as previously been described to confer the acute phe-
otype of SIVpbj14 to the SIVmac239 clone (Du et al.,
995, 1996). A tyrosine at position 17 could also be
eadily detected in mesenteric lymph nodes (49%),
hereas in thymus (19%), brain (31%), and lung (14%) the
requencies of the R3Y substitution were relatively low
FIG. 2. Cell-associated viral load in the macaques described in the
egend to Fig. 1. Virus was isolated by cocultivation of serial dilutions of
BMC with indicator CEMx174 cells and the endpoint calculated as
escribed (Stahl-Hennig et al., 1996). Viral loads are expressed as the
umber of infectious cells per 106 monkey PBMC. The end point was
ot reached for PBMC derived from SIVmac239DNU infected ma-
aques at 2 weeks postinfection. For abbreviations refer to the legend
f Fig. 1.Fig. 4). Analysis of PBMC samples and reisolated virus obtained at different time points after infection revealed
hat a Y at position 17 of the Nef sequence could first be
etected at 16 wpi, just prior to the dramatic increase in
27 antigenemia (Fig. 1). At the time of death 51% of the
roviral templates in PBMC, 77% of the reisolated virus,
nd 98% of the viral plasma RNA sequences contained
he Y17 substitution.
Mm8155 was initially infected with an SIVmac239 vari-
nt containing substitutions of 73/74PA3ED and
04D3R in Nef. Variants containing reversion of
04R3D and changes of 72N3D and 73E3K emerged
uring the first 4 weeks postinfection (Table 1). These
hanges restored the ability of Nef to downregulate CD4
urface expression and to enhance infectivity and repli-
ation (Table 1). In the remaining two animals, infected in
arallel with the same virus stock, selection for the same
hanges at amino acid positions 72, 73, and 204 in Nef
as observed (Iafrate et al., in preparation). However,
hese animals, which did not show the R17Y variation,
ad low levels of detectable p27 antigen and of viral RNA
nd did not show rapid disease progression. The tem-
oral correlation of the strong increase in viral load in
m8155 with the appearance of the R17Y change clearly
uggests that this alteration was associated with higher
irulence. Nonetheless, the possibility that changes else-
here in the virus genome contributed to the rapid pro-
ression cannot be entirely dismissed.
To test whether the variant selected in Mm8155 could
eplicate in resting primary monkey PBMC, normalized
mounts of p27 antigen containing virus, reisolated at
ifferent time points after infection, were used. Compa-
able levels of viral replication were observed for all
eisolates in PHA-stimulated PBMC (Fig. 5A). When rest-
ng PBMC were infected with the reisolated viruses and
timulated with PHA 3 days later, a progressive increase
n the ability to replicate was observed (Fig. 5B). Viral
FIG. 3. Percentage of CD41, CD41/CD291, and CD81 cells in the
eripheral blood of Mm8155. Numbers are expressed as a percentage
f total lymphocytes.
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65EMERGENCE OF THE SIVmac239 17R3Y VARIANTopulations reisolated from Mm8155 after 8 wpi repli-
ated with wild-type kinetics (Fig. 5B, and data not
hown). However, only virus reisolated at 16 and 21 wpi,
hen the R17Y substitution could be detected (Fig. 4),
eplicated efficiently in resting PBMC culture (Fig. 5C).
hus, the variant that emerged late in infection of
m8155 with an SIVmac239 Nef mutant showed the
nusual phenotype of SIVpbj14.
The viral populations reisolated from Mm8155 may con-
ain changes outside of the nef gene that affect replication.
herefore, we generated a set of SIVmac239 mutants dif-
ering only in the specific changes in nef selected in
m8155 (Table 1). All Nef variants replicated efficiently in
HA-stimulated PBMC (Fig. 6A). Substitutions of 73/
4PA3ED and 204D3R in Nef impaired the ability to stim-
late viral replication, when unstimulated PBMC were in-
ected and stimulated later (Fig. 6B). The variant, selected
arly in infection of Mm8155, predicting changes of 73/
4PA3KD, compared to the parental SIVmac239 clone
howed an intermediate phenotype. An additional substi-
ution of 72N3D fully restored replicative capacity under
he experimental conditions used (Fig. 6B). As expected,
FIG. 4. Quantitative detection of the CGA3TAT (17R3Y) mutation i
roducts were mixed at different molar ratios and sequenced as descri
as isolated directly from PBMC, positive virus reisolation bulk culture
NA and sequenced as described. The percentage of nef sequences
umbers below the curves indicate sequences of single nef-PCR clon
esenteric lymph node; Ln ax, axillary lymph node; wpi, weeks postin
; blue, C; black, G; red, T.nly the SIVmac239 R17Y and the Y-DKD Nef variants, and Hot the 239wt or the AxxA-Nef variants, replicated efficiently
n unstimulated PBMC (Fig. 6C).
Selection of acutely pathogenic Nef variants may occur
nnoticed in a significant number of rapid progressors of
IV infection. Therefore, we analyzed the status of nef
enes at the time of death in 14 rhesus macaques infected
ith the SIVmac239 that progressed to fatal disease be-
ween 9 and 52 wpi (Table 1). We did not observe selection
or Y17 in Nef in any of these animals (Table 2). Moreover,
he Y17 substitution was not detected in 3 macaques
oused at the New England Regional Primate Research
enter that died between 13 and 14 wpi with high levels of
27 antigenemia (P. O. Ilyinskii and R. C. Desrosiers, per-
onal communication). Thus, the appearance of the acute
athogenic SIVmac239 Y17 Nef variant in Mm8155 is un-
sual and coincided with the dramatic increase of plasma
iremia and the rapid progression to death.
DISCUSSION
Infection of rhesus macaques with the SIVmac239
lone results in an AIDS-like disease similar to human
n 17 of the Nef open reading frame. (Top row, left) PCR amplification
er Materials and Methods. (Top row, right, and bottom two rows) DNA
the tissues indicated or obtained after reverse transcription of plasma
ing a tyrosine was estimated from the standard curves shown above.
icting a Y at position 17 per total number of clones analyzed. LNmes,
; n.d., not determined. Colors used for the four nucleotides are green,n codo
bed und
s, from
predict
es pred
fectionIV-1 infection (Kestler et al., 1990; Wyand et al., 1996). It
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66 KIRCHHOFF ET AL.as recently been shown that the introduction of a single
7R3Y change in SIVmac239 Nef drastically changes its
iological properties and re-creates the phenotype of the
cutely pathogenic SIVpbj14 strain (Du et al., 1995, 1996;
asseville et al., 1996). In this study we demonstrate the
election of the R17Y substitution during late stages of
IVmac infection.
To ensure the greatest possibility of transmission, it is
learly disadvantageous for SIV to kill its host shortly
FIG. 5. Replication kinetics of virus reisolated from macaque Mm8155
or 3 days prior to infection (A) or unstimulated PBMC were infected an
ere infected with virus containing 2 ng of p27 obtained from bulk coc
irus production was measured by reverse transcriptase assay as desc
rom three different donors.
FIG. 6. Replication kinetics of cloned SIVmac239 nef variant rhesus
nd unstimulated PBMC were infected as described in the legend to F
3rd codon of nef (Regier and Desrosiers, 1989; Kestler et al., 1991). T
o 239wt: AxxA, 104 P3A, and 107 P3A (Lang et al., 1997); 73E74
4NPA3DKD; Y-DKD, 17R3Y, and 72-74NPA3DKD; Y17, 17R3Y. Similar resufter infection, like SIVpbj14 does. The SIVmac239 17Y-
ef variant, which became predominant in the rapidly
rogressing macaque Mm8155, was associated with
ery high levels of viral replication and required the
ubstitution of all three nucleotides in codon 17
CGA3TAT). At least during the final stage of infection of
m8155 the 17Y-Nef variant seems to have a substantial
rowth advantage over SIV expressing “normal” Nef.
ince only a single amino acid change in Nef is required
rent time points in rhesus PBMC. Rhesus PBMC were PHA-stimulated
lated at day 3 (B) or not stimulated (C). Approximately 250,000 PBMC
ns. The cells were cultured in RPMI 1640 medium with 10% FCS and
nder Materials and Methods. Similar results were obtained with PBMC
Prestimulated PBMC (A), cells stimulated at 3 days postinfection (B),
IVmac239 nef* contains a premature in-frame TAA stop signal at the
r variants predict the following amino acid changes in Nef compared
73/74PA3ED, and 204D3R; 73K74D, 73/74PA3KD; 72-74DKD, 72-at diffe
d stimu
ultivatio
ribed uPBMC.
ig. 5. S
he othe
D204R,lts were obtained in two independent experiments.
t
m
t
q
t
p
i
P
m
v
c
e
i
e
s
p
s
S
a
p
S
i
1
1
b
v
e
p
e
a
p
p
i
a
t
f
a
w
a
t
2
p
w
d
c
v
s
f
e
w
s
o
a
g
m
s
m
l
a
a eath.
67EMERGENCE OF THE SIVmac239 17R3Y VARIANTo change the biological phenotype, and since the pri-
ate lentiviruses have very high mutation rates, why is
his acutely pathogenic form not observed more fre-
uently after experimental infection? One likely explana-
ion is that this form does occur, but does not become
redominant because it is efficiently eliminated by the
mmune response. In the initial study with the macaque
Bj, the animal was already immunodeficient several
onths prior to the appearance of the acute pathogenic
ariant (Fultz et al., 1989). The animal in the present study
learly showed the characteristics of a rapid progressor
arly in infection. It did not mount an efficient humoral
mmune response, already had high levels of antigen-
mia, and had lost more than 50% of its CD41/CD291
ubset before the Y17-Nef variant arose. In further sup-
ort of this hypothesis, reversions of 17Y317R are ob-
erved in macaques experimentally infected with the
IVmac239 YE-Nef variant, when the animals survive the
cute phase of infection (Z. Du and R. C. Desrosiers,
ersonal communication). The acutely pathogenic
IVpbj14 and SIVmac239 Y17-Nef variants replicate well
n resting PBMC (Dewhurst et al., 1990; Du et al., 1995,
996; Fultz et al., 1989; Fultz and Zack, 1994; Israel et al.,
993). In healthy animals, most CD41 lymphocytes in the
lood or lymphatic tissues are resting or minimally acti-
ated, and a virus variant that extends its tropism to
fficient replication in the large pool of resting cells
resumably should have a substantial advantage. How-
ver, the antiviral immune response in most infected
T
Alterations in Nef Sequences Amplifie
Rhesus
macaque No.
Infecting
SIVmac239a Death wpib
8155 73/74/204 21
1819 nef-open 20
1827 nef-open 20
1836 nef-open 25
1843 nef-open 45
7058 nef-open 20
7198 nef-open 21
7200 nef-open 52
7201 nef-open 38
7203 nef-open 45
7204 nef-open 29
7208 AxxA-Nef 9
7212 AxxA-Nef 18
8143 nef-open 45
8148 nef-open 33
Note. n.d., not determined.
a The SIVmac239 Nef variants have been described previously (Kest
b Animals died at the indicated weeks postinfection.
c Plasma antigenemia. The limit of detection is approximately 0.02 n
d DNA was isolated directly from PBMC or positive virus reisolation
s described (Lang et al., 1997). Only differences compared to the SIVm
re indicated. Plasma and rPBMC samples were collected at time of dnimals already leads to cytokine production and lym- ahocyte activation. Thus, activated CD41 cells that
resent a good substrate for replication of virus express-
ng “normal” Nef may already be present in large
mounts, minimizing the selective advantage of a variant
hat replicates in resting cells. Mm8155 was initially in-
ected with an SIVmac239 Nef variant containing three
mino acid substitutions, 73/74PA3ED and 204D3R,
hich impaired the ability of Nef to downregulate CD4
nd reduced viral replication in primary culture. When
he Y17 change appeared at 16 weeks postinfection, the
04D3R change was reverted for 14 weeks, and at
ositions 72–74 some alterations were present from 4
eeks postinfection, which restored the ability of Nef to
ownregulate CD4 and to enhance infectivity and repli-
ation efficiency (Table 1). Since the animal showed high
iral load and was immunodeficient before the Y17 sub-
titution occurred, this form of Nef seems to be fully
unctional in vivo. Nonetheless, the possibility cannot be
xcluded that the 72-74NPA3DKD substitutions that
ere present did not fully restore Nef activity and that the
election for Y17 essentially represents a mutation that
vercompensates for these attenuating changes. Over-
ll, the frequency of the appearance of acutely patho-
enic SIV variants may be underestimated, because in
ost studies the status of the nef genes during the late
tages of infection is not investigated.
Pathological lesions in the gastrointestinal tract, the
arked enlargement of the GALT system, and the high
evels of viremia observed in Mm8155 resemble the char-
Progressors of SIVmac239 Infection
tigenc
ml) Mutation(s) in Nef d
.6 R173Y;NED72-743DKD
. None
. None
. M73K; R113G
. None
.3 T273I
. None
.3 None
.0 R113K; 23A3E; 41Q3R; 75E3T; 94D3E; 96D3G
.0 R113K; R303Q
.8 None
.8 P1043A; P1073A
.6 P1043A; P1073A
. R113K; 75E3V
. None
l., 1991; Lang et al., 1997).
ltures and the sequence of the first 120 amino acids was determined
Nef sequence that were present in the majority of nef genes analyzedABLE 2
d from
p27 An
(ng/
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68 KIRCHHOFF ET AL.us macaques with the SIVpbj14 or the SIVmac239 YE-
ef variants (Dewhurst et al., 1990; Fultz et al., 1989;
ultz, 1994; Israel et al., 1993; Sasseville et al., 1996).
owever, the development of acute disease apparently
roceeds faster when the animals are initially infected
ith these variants. Inoculation of SIVpbj14 in macaques
sually results in death within 8 days postinoculation
Fultz et al., 1989; Fultz, 1994; Israel et al., 1993;
chwiebert and Fultz, 1994), and for experimental infec-
ion with SIVmac239 YE-Nef the peak of clinical symp-
oms occurred 9 days after infection (Du et al., 1995;
asseville et al., 1996). In the present study the 17Y-Nef
ariant was first observed at 16 weeks postinfection, 5
eeks prior to death. In the initial study of SIVpbj14, the
IV variant showing the ability to replicate in unstimu-
ated PBMC appeared already several months before the
nimal died (Fultz et al., 1989; Tao and Fultz, 1995). One
xplanation for these differences is that a larger pool of
D41 T-cells is present after initial infection. When acute
athogenic variants emerge in animals that are already
everely immunodeficient, the absolute numbers of
D41 T-lymphocytes and the ability to regenerate these
ells are reduced and the number of target cells that
llow viral replication may be more restrictive for the
pread of the virus. Moreover, even the inefficient im-
une response in the rapid progressors’ infection may
low the spread of the virus.
After the Y17-Nef variant was first observed at 16
eeks (Fig. 4), the levels of plasma viremia increased
ery rapidly to values about 100-fold higher than com-
only observed in SIVmac239 infection. Exceedingly
igh levels of plasma viremia, however, have been de-
cribed for infection with the acutely pathogenic SIV
ariants (Schwiebert and Fultz, 1994). At the time of
eath, between 50 and 70% of the proviral sequences
mplified from spleen, lymph nodes, and PBMC, and
lmost 100% of the viral genomic RNA in plasma, con-
ained the R3Y substitution (Fig. 4). In contrast to the
ymphatic tissues, the frequency of the 17Y-Nef variant
as much lower in lung and brain, where viral replication
s restricted mainly to monocytes/macrophages. The pa-
ental SIVmac239 strain enters macrophages, but repli-
ates very inefficiently (Mori et al., 1993). Thus, the
pread of the virus to macrophages may proceed with
uch slower kinetics compared to lymphatic tissues.
oreover, the 17Y-Nef variant may not have a replicative
dvantage in these cells, even though monocytes/mac-
ophages are required for replication of the Y17-Nef
ariant in unstimulated culture (Du et al., 1995). We do not
ave a good explanation for the high frequency of the
17-Nef variant in the kidneys (68%) and the low fre-
uency in the thymus (19%). In other rapid progressors
o CD41 T-lymphocytes could be detected in the thymus
data not shown). It seems possible that the nef gene
equences were predominantly amplified from infected
troma cells. hThe ability of HIV and SIV Nef to cause T-cell activation
nd enhanced replication in primary culture is well doc-
mented (Alexander et al., 1997; Miller et al., 1994; Skow-
onski et al., 1993; Spina et al., 1994). The Y17-Nef variant
s obviously “superactive” in this particular Nef activity.
owever, multiple Nef functions may be relevant in vivo.
arly in infection, and in severely immunocompromised
nimals, the ability to enhance viral replication by lym-
hocyte activation may be advantageous for virus repli-
ation. After the onset of an effective antiviral immune
esponse, the downregulation of CD4 and/or MHC class
molecules by Nef may help the virus to evade the
mmune system. It remains to be elucidated whether the
17-Nef is fully functional in these activities and whether
articularly active nef alleles are also present in some
apid progressors of HIV-1 infection.
MATERIALS AND METHODS
nfection of rhesus macaques and their clinical and
erovirological assessment
Three purpose-bred healthy juvenile rhesus ma-
aques (Macaca mulatta) of Indian origin with a body
eight between 3 and 4 kg were infected intravenously
ith culture supernatant from COS-7 cells transfected
ith an SIVmac239 nef variant (72/73PA3ED and
04D3R). The construction and in vitro properties of this
ef variant will be described elsewhere (Iafrate et al.,
anuscript in preparation). The inoculated volume con-
ained 10 ng of p27 of the virus determined by a com-
ercial HIV-1/HIV-2 antigen capture assay (Immunoge-
etics, Zwijndrecht, Belgium). The animals were sero-
egative for SIV, D-type retroviruses, and STLV-1 at the
ime of infection. Citrated blood for the preparation of
lasma and PBMC was collected at regular intervals for
erological, virological, and immunological investiga-
ions. Capsid antigen levels in the plasma were deter-
ined with the antigen capture assay mentioned above.
he cell-associated viral loads were determined by a
imiting dilution coculture assay as described previously
Stahl-Hennig et al., 1996), except that CEMx174 cells
nstead of C8166 cells were used. The humoral immune
esponse of the infected macaques against viral compo-
ents was measured by an ELISA using detergent-dis-
upted whole SIVmac251 in optimal concentrations for
ntigen coating (Stahl-Hennig et al., 1992). Phenotyping
f PBMCs was performed employing three-color fluores-
ence analysis on an EPICS XL flow cytometer (Coulter,
refeld, Germany) with FITC-, phycoerythrin-, or Tricolor-
onjugated mouse mAbs specific for CD (OKT4; Orthodi-
gnostic Systems, Neckargmu¨nd, Germany), CD8
Leu2A; Becton Dickinson, Heidelberg, Germany), or
D29 (4B4; Coulter). Necropsy was performed when
onkeys became highly moribund due to AIDS-related
ymptoms and included routine gross pathology and
istological examination.
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69EMERGENCE OF THE SIVmac239 17R3Y VARIANTequence analysis
SIV DNA sequences spanning nef either were ampli-
ied directly from DNA isolated from rhesus PBMC or
rgan tissue with a nested PCR approach (Kirchhoff et
l., 1994) or were obtained from DNA isolated from virus-
ositive PBMC/CEMx174 cocultures by a single round of
mplification. Viral plasma RNA was isolated with the
NA Kit (Diagen, Basel, Switzerland), reverse transcribed
ith superscript reverse transcriptase (Gibco BRL, Eg-
enstein, Germany), and subjected to a standard nested
CR approach. PCR fragments were purified with the
uiaquick gel extraction kit (Qiagen) and sequenced
irectly or after subcloning into the pCRII vector (Invitro-
en Corp., San Diego, CA) with the PRISM sequencing
it (Perkin–Elmer, Foster City, CA) and an automated
pplied Biosystems 373 DNA sequencer following the
rotocols of the manufacturers. Nucleotide changes
ere quantitated as described (Lang et al., 1997), with
ef containing Y17 (TAT) and 239wt Nef R17 (CGA) mixed
t different molar ratios for standard curves.
eplication in rhesus PBMC
Rhesus macaque PBMC were isolated using lympho-
yte separation medium (Organon Teknika Corp.,
urham, NC). Isolated PBMC were either prestimulated
or 3 days with 4 mg phytohemagglutinin per milliliter
Sigma, Munich, Germany) or immediately infected with-
ut mitogen stimulation with reisolated virus containing 2
g of p27 antigen and kept in RPMI 1640 with 10% fetal
alf serum. Residual virus was removed by washing the
ells 16–18 h after infection. Infected unstimulated PBMC
ere maintained in this medium or stimulated at 3 days
ostinfection with 4 mg PHA per milliliter for 3 days,
ashed, and maintained in RPMI 1640 medium supple-
ented with 20% FCS and 50 U/ml IL-2 (Boehringer,
annheim, Germany). Virus production was measured
y reverse transcriptase assay (Potts, 1990).
onstruction of SIVmac239 Nef mutants
Site-directed mutagenesis and generation of full-
ength SIVmac239 nef mutants were performed as de-
cribed previously (Lang et al., 1997).
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